Aleniglipron GLP-1 Pill Shows 12.1% Weight Loss in 36 Weeks
A new once-daily oral GLP-1 drug is adding momentum to the rapidly changing obesity-treatment market. In a Phase 2b trial…
A new once-daily oral GLP-1 drug is adding momentum to the rapidly changing obesity-treatment market. In a Phase 2b trial…